U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07290257) titled 'Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli(R) in Patients With Alagille Syndrome in the European Union (LEAP-EU)' on Sept. 17.
Brief Summary: The key objectives of this low-intervention clinical study are to evaluate tolerability, long-term safety and long-term efficacy for patients with Alagille syndrome (ALGS) who are prescribed Livmarli.
Study Start Date: Sept. 25
Study Type: INTERVENTIONAL
Condition:
Alagille Syndrome
Intervention:
DRUG: Livmarli Oral Product
Participants will be treated according to standard of care for the duration of the study and Schedule of Assessments.
Recrui...